N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further positive update on its
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 15th April 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, WTI, Asiamet,
N4 Pharma PLC (AIM:N4P) in-vitro siRNA update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further encouraging update
RNS Hotlist with Zak Mir: GENF, BOOM, YCA, ROCK, VRS, AVCT, ANGS, CYK, PXEN & N4P
Genflow Bioscience (GENF) yesterday afternoon announced two research grants totally €2.9m to develop gene therapies that increase human life spans with better health.
N4 Pharma PLC (AIM:N4P) Patent Grant
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to announce that the University of Queensland has informed
N4 Pharma PLC (AIM:N4P) Nanogenics Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide an update on its
N4 Pharma PLC (AIM:N4P) AAV Viral Vector Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further successful update
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 5th January 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, ANGLE, Bluebird,
Share Talk Weekly Small Cap Movers & Shakers, Saturday 23rd December 2023
The FTSE AIM-All-Share Index joined in the holiday cheer, rising by 170 basis points to end the week just over the 751 mark. The junior market slightly outperformed the FTSE
N4 Pharma PLC (AIM:N4P) Oral Delivery Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a positive update on its ongoing
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 13th December 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Audioboom, AFC, Anglesey,
N4 Pharma PLC (AIM:N4P) Nuvec® R&D and Strategy Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an encouraging update on its ongoing in